Lilly (Eli)

LLY

HealthcareNYQ$820.1B

LLY SEC filings last scanned 4 Oct 2026, 18:57 UTC

CEO Timeline

David A. RicksCurrent

Jan 2017 — Present(9y 9mo)

David A. Ricks was appointed president and chief executive officer of Eli Lilly and Company, effective January 1, 2017, succeeding John Lechleiter.

1 source filing — click to expand

John C. Lechleiter

Apr 2008 — Dec 2016(8y 8mo)

John C. Lechleiter was appointed President and CEO of Eli Lilly, effective April 1, 2008, succeeding Sidney Taurel.

planned retirement

3 source filings — click to expand

Sidney Taurel

Since at least Mar 2005 — Mar 2008(3y)

planned retirement

2 source filings — click to expand